MedPath

Stellate Gnaglion Block in Refractory Bell's Palsy

Not Applicable
Completed
Conditions
Facial Palsy
Neuropathy
Interventions
Procedure: Stellate Ganglion Block Group
Registration Number
NCT05094245
Lead Sponsor
Assiut University
Brief Summary

Idiopathic facial nerve palsy (Bell's palsy) is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is inteneded to increase blood flow and promotes nerve regeneration.

Detailed Description

the conventional systemic corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective.

Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) on idiopathic persistant facial nerve palsy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed by clinical and neurological assessment as one-sided idiopathic facial palsy
  • Age 18 to 60
  • ASA Ⅰ~Ⅲ
Exclusion Criteria
  • diabetic
  • coagulation dysfunction
  • mental or cognitive dysfunclion
  • allergy to injected medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stellate ganglion blockStellate Ganglion Block GroupPatients underwent a stellate-ganglion block at the anterolateral aspect of the C6 vertebra. After local analgesia (lidocaine 2%), a 22-gauge Quincke needle was placed in the anterolateral aspect of the C6 vertebral body. When the needle contacted the bone, it was drawn back 1 mm. 5 mL of 0·5% ropivacaine was subsequently injected next to the stellate ganglion to produce a sympathetic block.The effect of the stellate-ganglion block on the sympathetic nervous system was confirmed by the presence of Horner's syndrome (ie, facial anhydrosis, enophthalmos, ptosis, swelling of the lower eyelid, miosis, and blood-shot conjunctiva), and an increase in the temperature of the right hand of at least 2°F from baseline.
Primary Outcome Measures
NameTimeMethod
House Brackmann grading scaleBaseline ,change from baseline House-Brackmann at 7th day,one month,two month, three month

The House-Brackmann scale is a nerve grading system, It is used to characterize the severity of a facial paralysis patient's symptoms.

Grade I : 100% functioning Grade VI : 0% function

Secondary Outcome Measures
NameTimeMethod
Likert scalebefore intervention , and directly after intervention

Likert scale (Patients' satisfaction) is typically a five; 1 =strongly dis-satisfied and 5= strongly satisfied

Trial Locations

Locations (1)

Emad Zarief Kamel Said

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath